Please tell us about Puma Biotechnology. Mr. Auerbach: I’d be more than happy to. Puma is a biotech company that is dedicated to the development and commercialization of drugs for the treatment of ...

Let’s start with a look at your coverage, and how it might have changed since we spoke in 2023. Mr. Lichtman: Sure. I cover a large group of medical device companies from micro cap to mega cap. I ...

Vlad Vitoc, M.D., is Chairman of Board, Chief Executive Officer, and President of MAIA Biotechnology Inc. Dr. Vitoc has a broad array of experience across commercial strategic analysis and ...

Jason Wittes is a Managing Director and Senior Research Analyst at Roth Capital Partners. He has over 20 years of health care investment experience on both the buy side and sell side. Prior to ...

Ilan Sobel has been the CEO of BioHarvest Sciences Inc. since July 2020. He brought the company’s first product, VINIA, to North America, building a direct-to-consumer machine that is now ...

Please give us a brief overview of NeurAxis and its services. Mr. Carrico: Sure. NeurAxis is an early growth stage med-tech company, focused on treating disorders of the gut-brain interaction in the ...

Hartaj Singh is a Founding Partner of Tecumseh Partners, advising biotech companies on valuation, strategy, and investor engagement. He also writes The Biotech Capital Compass, a newsletter ...

Cuong Do is President and CEO of BioVie Inc. Prior to his appointment with BioVie, Mr. Do was President of Samsung Global Strategy Group where he helped to set the strategic direction for Samsung ...